Literature DB >> 7519006

Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells.

K Schmidt1, P Klatt, B Mayer.   

Abstract

Uptake of the nitric oxide synthase inhibitors NG-methyl-L-arginine (L-NMA) and NG-nitro-L-arginine (L-NNA) by macrophages is mediated by two different mechanisms. Activation of the cells with cytokines resulted in an up-regulation of L-NMA uptake but did not affect L-NNA transport. Characterization of the transport sites revealed that uptake of L-NMA is mediated by a cationic amino acid transporter (system y+) whereas a neutral amino acid transporter (system L) accounts for the uptake of L-NNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519006      PMCID: PMC1137080          DOI: 10.1042/bj3010313

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: requirement for inducible and constitutive components.

Authors:  D J Stuehr; N S Kwon; S S Gross; B A Thiel; R Levi; C F Nathan
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

2.  Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte.

Authors:  G Wiemer; A Wellstein; D Palm; H M von Hattingberg; D Brockmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

3.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

4.  Arginine is a physiological precursor of endothelium-derived nitric oxide.

Authors:  H H Schmidt; H Nau; W Wittfoht; J Gerlach; K E Prescher; M M Klein; F Niroomand; E Böhme
Journal:  Eur J Pharmacol       Date:  1988-09-13       Impact factor: 4.432

5.  Identification of arginine as a precursor of endothelium-derived relaxing factor.

Authors:  I Sakuma; D J Stuehr; S S Gross; C Nathan; R Levi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.

Authors:  K Schmidt; P Klatt; B Mayer
Journal:  Mol Pharmacol       Date:  1993-09       Impact factor: 4.436

7.  NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase.

Authors:  N M Olken; M A Marletta
Journal:  Biochemistry       Date:  1993-09-21       Impact factor: 3.162

8.  Characterization of system L and system y+ amino acid transport activity in cultured vascular smooth muscle cells.

Authors:  B C Low; I K Ross; M R Grigor
Journal:  J Cell Physiol       Date:  1993-09       Impact factor: 6.384

9.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

10.  Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of L-arginine transport, in activated murine macrophage J774 cells.

Authors:  A R Baydoun; R G Bogle; J D Pearson; G E Mann
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

View more
  12 in total

1.  Na+ - and Cl- -coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B(0,+).

Authors:  T Hatanaka; T Nakanishi; W Huang; F H Leibach; P D Prasad; V Ganapathy; M E Ganapathy
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Transport of N(G)-nitro-L-arginine across intestinal brush border membranes by Na+ -dependent and Na+-independent amino acid transporters.

Authors:  T Hatanaka; Y Nabuchi; H Ushio
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

3.  Interaction of nitric oxide synthase inhibitors and their D-enantiomers with rat neutrophil luminol dependent chemiluminescence response.

Authors:  M Dikshit; S S Chari; P Seth; R Kumari
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

4.  Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide.

Authors:  S M Wileman; G E Mann; A R Baydoun
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

5.  Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies.

Authors:  R A Rutherford; A McCarthy; M H Sullivan; M G Elder; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

6.  Protective Role of Arginase II in Cerebral Ischemia and Excitotoxicity.

Authors:  Abdullah Shafique Ahmad; Zahoor Ahmad Shah; Sylvain Doré
Journal:  J Neurol Neurosci       Date:  2016-04-29

7.  Oxygen tension limits nitric oxide synthesis by activated macrophages.

Authors:  C C McCormick; W P Li; M Calero
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

8.  Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.

Authors:  S Pfeiffer; E Leopold; K Schmidt; F Brunner; B Mayer
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

Review 9.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

10.  Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene.

Authors:  Chinedu Njoku; Sally E Self; Philip Ruiz; Ann F Hofbauer; Gary S Gilkeson; Jim C Oates
Journal:  J Investig Med       Date:  2008-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.